Hosp. Univ. Son Espases

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic myeloid leukaemia1 trial
• Multiple myeloma1 trial
• Myelodysplastic syndromes1 trial

Phase

• Phase 21 trial

Status

• Active, not recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Janssen Pharmaceutica N.V., Belgium1 trial
• Janssen Research & Development, LLC1 trial

Running trials

• Active, not recruiting

  A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma

  NCT05160584· Janssen Pharmaceutica N.V., Belgium· Source

Closed trials

• Withdrawn

  A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)

  NCT04264806· Phase 2· Janssen Research & Development, LLC· Source